{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:19:08Z","timestamp":1725754748865},"reference-count":20,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1507\/endocrj.ej24-0090","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T22:11:13Z","timestamp":1721945473000},"page":"873-880","source":"Crossref","is-referenced-by-count":0,"title":["Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients"],"prefix":"10.1507","volume":"71","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tsuchikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitaka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimichi","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Noji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"doi-asserted-by":"crossref","unstructured":"1 Liu M, Li N, Tang H, Chen L, Liu X, et al. (2023) The mutational, prognostic, and therapeutic landscape of neuroendocrine neoplasms. Oncologist 28: e723\u2013e736.","key":"1","DOI":"10.1093\/oncolo\/oyad093"},{"doi-asserted-by":"crossref","unstructured":"2 Ke\u010dk\u00e9\u0161 \u0160, Palaj J, Waczul\u00edkov\u00e1 I, Dyttert D, Mojtov\u00e1 E, et al. (2021) Pretreatment levels of chromogranin A and neuron-specific enolase in patients with gastroenteropancreatic neuroendocrine neoplasia. In Vivo 35: 2863\u20132868.","key":"2","DOI":"10.21873\/invivo.12574"},{"doi-asserted-by":"crossref","unstructured":"3 van Adrichem RC, Kamp K, Vandamme T, Peeters M, Feelders RA, et al. (2016) Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors. Ann Oncol 27: 746\u2013747.","key":"3","DOI":"10.1093\/annonc\/mdv626"},{"doi-asserted-by":"crossref","unstructured":"4 Corsello A, Di Filippo L, Massironi S, Sileo F, Dolcetta Capuzzo A, et al. (2018) Vasostatin-1: a novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms. PLoS ONE 13: e0196858.","key":"4","DOI":"10.1371\/journal.pone.0196858"},{"doi-asserted-by":"crossref","unstructured":"5 Modlin IM, Kidd M, Bodei L, Drozdov I, Aslanian H (2015) The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract. Am J Gastroenterol 110: 1223\u20131232.","key":"5","DOI":"10.1038\/ajg.2015.160"},{"doi-asserted-by":"crossref","unstructured":"6 Modlin IM, Kidd M, Frilling A, Falconi M, Filosso PL, et al. (2021) Molecular genomic assessment using a blood-based mRNA signature (NETest) is cost-effective and predicts neuroendocrine tumor recurrence with 94% accuracy. Ann Surg 274: 481\u2013490.","key":"6","DOI":"10.1097\/SLA.0000000000005026"},{"doi-asserted-by":"crossref","unstructured":"7 Bodei L, Raj N, Do RK, Mauguen A, Krebs S, et al. (2023) Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in Neuroendocrine Tumors. J Nucl Med 64: 567\u2013573.","key":"7","DOI":"10.2967\/jnumed.122.264363"},{"doi-asserted-by":"crossref","unstructured":"8 Al-Toubah T, Cives M, Valone T, Blue K, Strosberg J (2021) Sensitivity and specificity of the NETest: a validation study. Neuroendocrinology 111: 580\u2013585.","key":"8","DOI":"10.1159\/000509866"},{"doi-asserted-by":"crossref","unstructured":"9 Puliani G, Di Vito V, Feola T, Sesti F, Centello R, et al. (2022) NETest: a systematic review focusing on the prognostic and predictive role. Neuroendocrinology 112: 523\u2013536.","key":"9","DOI":"10.1159\/000518873"},{"doi-asserted-by":"crossref","unstructured":"10 van Treijen MJC, Korse CM, Verbeek WH, Tesselaar MET, Valk GD (2022) NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance. Endocr Connect 11: e220146.","key":"10","DOI":"10.1530\/EC-22-0146"},{"doi-asserted-by":"crossref","unstructured":"11 Pavel M, Jann H, Prasad V, Drozdov I, Modlin IM, et al. (2017) NET blood transcript analysis defines the crossing of the clinical rubicon: when stable disease becomes progressive. Neuroendocrinology 104: 170\u2013182.","key":"11","DOI":"10.1159\/000446025"},{"doi-asserted-by":"crossref","unstructured":"12 Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) TNM classification of malignant tumours (8th). Wiley-Blackwell, Chichester, UK.","key":"12","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"doi-asserted-by":"crossref","unstructured":"13 Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, et al. (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31: 1770\u20131786.","key":"13","DOI":"10.1038\/s41379-018-0110-y"},{"doi-asserted-by":"crossref","unstructured":"14 P\u0119czkowska M, Cwikla J, Kidd M, Lewczuk A, Kolasinska-\u0106wik\u0142a A, et al. (2017) The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas. Eur J Endocrinol 176: 143\u2013157.","key":"14","DOI":"10.1530\/EJE-16-0727"},{"doi-asserted-by":"crossref","unstructured":"15 Modlin IM, Kidd M, Falconi M, Filosso PL, Frilling A, et al. (2021) A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility. Ann Oncol 32: 1425\u20131433.","key":"15","DOI":"10.1016\/j.annonc.2021.08.1746"},{"doi-asserted-by":"crossref","unstructured":"16 Zhang C, Huang Y, Long J, Yao X, Wang J, et al. (2019) Serum chromogranin A for the diagnosis of gastroenteropancreatic neuroendocrine neoplasms and its association with tumour expression. Oncol Lett 17: 1497\u20131504.","key":"16","DOI":"10.3892\/ol.2018.9795"},{"doi-asserted-by":"crossref","unstructured":"17 Bodei L, Kidd M, Modlin IM, Severi S, Drozdov I, et al. (2016) Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors. Eur J Nucl Med Mol Imaging 43: 839\u2013851.","key":"17","DOI":"10.1007\/s00259-015-3250-z"},{"doi-asserted-by":"crossref","unstructured":"18 Modlin IM, Kidd M, Oberg K, Falconi M, Filosso PL, et al. (2021) Early identification of residual disease after neuroendocrine tumor resection using a liquid biopsy multigenomic mRNA signature (NETest). Ann Surg Oncol 28: 7506\u20137517.","key":"18","DOI":"10.1245\/s10434-021-10021-1"},{"doi-asserted-by":"crossref","unstructured":"19 \u00d6berg K, Califano A, Strosberg JR, Ma S, Pape U, et al. (2020) A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood. Ann Oncol 31: 202\u2013212.","key":"19","DOI":"10.1016\/j.annonc.2019.11.003"},{"doi-asserted-by":"crossref","unstructured":"20 Bodei L, Kidd MS, Singh A, van der Zwan WA, Severi S, et al. (2020) PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest. Eur J Nucl Med Mol Imaging 47: 895\u2013906.","key":"20","DOI":"10.1007\/s00259-019-04601-3"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/9\/71_EJ24-0090\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T04:09:08Z","timestamp":1725682148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/9\/71_EJ24-0090\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0090","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"EJ24-0090"}}